Research workbench
Vim-2-nat, discovery of novel inhibitor scaffolds against the metallo-beta-lactamase vim-2 by spr based fragment screening
Analyse Vim-2-nat, discovery of novel inhibitor scaffolds against the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 5ACU
- Type
- protein
- Length
- 230 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase
- EC
- 3.5.2.6
- UniProt
- Q9K2N0
- Ligands
- ZN, CL, OH
- Pockets
- 1 · best druggability 0.50
Structure
x-ray diffraction · 1 distinct chain · 26% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase (EC 3.5.2.6) | protein | 230 | 26% helix, 27% strand | Q9K2N0 |
Ligands and binding sites
- ZN · Zinc ion · metal · 3 copies · chains A
- CL · Chloride ion · ion · 2 copies · chains A
- OH · Hydroxide ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 124 | 0.50 | 0.80 | 18 | OH, ZN |
Compared structures
- 5ACU · VIM-2-NAT, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9K2N0
- Elsewhere: RCSB PDB 5ACU · PDBe 5ACU · UniProt Q9K2N0
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.